Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

A specific mutation in PA-PLA1α causes abnormal hair growth.

Certain blood markers, especially MLR, can help diagnose alopecia areata.

The Fas/FasL pathway may play a role in alopecia areata.

The patient's hair improved after treatment, but the genetic link is unclear.

Increased PPARGC1α relates to hair thinning in common baldness.

Activated protein C helps protect mice from long-term radiation damage.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Apremilast did not work for treating severe alopecia areata.

A genetic marker linked to a type of hair loss was found in most patients studied.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

PRP is an effective and safe treatment for alopecia areata.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

A specific gene variant may increase the risk of developing Alopecia Areata.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Upadacitinib may cause hair loss.

A new model uses specific blood markers to predict if children's hair loss will return.

Alefacept does not effectively treat severe alopecia areata.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

People with alopecia areata have higher insulin resistance.